Effra Lifesciences
Sitagliptin (50mg) + Metformin (0mg)
Dipsita Met Tablet PR is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus.
Tablet PR
Dipsita Met Tablet PR is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may reduce your chances of having a heart attack or stroke.
Use it as advised by your doctor or check the label for directions before use. Dipsita Met Tablet PR is to be taken with food.
Dipsita Met Tablet PR is a combination of two medicines: sitagliptin and metformin. Sitagliptin help your pancreas produce more insulin, facilitate effective use of insulin by the body, and reduce excess sugar that your liver makes. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Together, they provide better control of blood sugar.
You have been prescribed this combination medicine as it can control blood sugar better than metformin alone. Take it with food to lower your chance of having an upset stomach. Take it in addition to regular exercise and healthy diet to lower levels of blood sugar. Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines. Monitor your blood sugar level regularly while you are taking this medicine.